2021
Vondráček, Jan; Machala, Miroslav
The Role of Metabolism in Toxicity of Polycyclic Aromatic Hydrocarbons and their Non-genotoxic Modes of Action. Journal Article
In: Current drug metabolism, vol. 22, no. 8, pp. 584–595, 2021, ISSN: 1875-5453 1389-2002, (Place: Netherlands).
Abstract | Links | BibTeX | Tags: Activation, AhR, Animals, Benzo[a]pyrene, Cell Proliferation, Cell Survival, cell-to-cell communication, DNA Damage, Environmental Pollutants/*pharmacokinetics/*toxicity, Humans, Metabolic, Mutagens/*pharmacokinetics/*toxicity, oxidative stress, PAH metabolism., Polycyclic Aromatic Hydrocarbons/*pharmacokinetics/*toxicity
@article{vondracek_role_2021,
title = {The Role of Metabolism in Toxicity of Polycyclic Aromatic Hydrocarbons and their Non-genotoxic Modes of Action.},
author = {Jan Vondráček and Miroslav Machala},
doi = {10.2174/1389200221999201125205725},
issn = {1875-5453 1389-2002},
year = {2021},
date = {2021-01-01},
journal = {Current drug metabolism},
volume = {22},
number = {8},
pages = {584–595},
abstract = {Polycyclic aromatic hydrocarbons (PAHs) represent a class of widely distributed environmental pollutants that have been primarily studied as genotoxic compounds. Their mutagenicity/genotoxicity largely depends on their oxidative metabolism leading to the production of dihydrodiol epoxide metabolites, as well as additional metabolites contributing to oxidative DNA damage, such as PAH quinones. However, both parental PAHs and their metabolites, including PAH quinones or hydroxylated PAHs, have been shown to produce various types of non-genotoxic effects. These include e.g., activation of the aryl hydrocarbon receptor and/or additional nuclear receptors, activation of membrane receptors, including tyrosine kinases and G-protein coupled receptors, or activation of intracellular signaling pathways, such as mitogen-activated protein kinases, Akt kinase and Ca(2+)-dependent signaling. These pathways may, together with the cellular DNA damage responses, modulate cell proliferation, cell survival or cell-to-cell communication, thus contributing to the known carcinogenic effects of PAHs. In the present review, we summarize some of the known non-genotoxic effects of PAHs, focusing primarily on those that have also been shown to be modulated by PAH metabolites. Despite the limitations of the available data, it seems evident that more attention should be paid to the discrimination between the potential non-genotoxic effects of parental PAHs and those of their metabolites. This may provide further insight into the mechanisms of toxicity of this large and diverse group of environmental pollutants.},
note = {Place: Netherlands},
keywords = {Activation, AhR, Animals, Benzo[a]pyrene, Cell Proliferation, Cell Survival, cell-to-cell communication, DNA Damage, Environmental Pollutants/*pharmacokinetics/*toxicity, Humans, Metabolic, Mutagens/*pharmacokinetics/*toxicity, oxidative stress, PAH metabolism., Polycyclic Aromatic Hydrocarbons/*pharmacokinetics/*toxicity},
pubstate = {published},
tppubtype = {article}
}
Polycyclic aromatic hydrocarbons (PAHs) represent a class of widely distributed environmental pollutants that have been primarily studied as genotoxic compounds. Their mutagenicity/genotoxicity largely depends on their oxidative metabolism leading to the production of dihydrodiol epoxide metabolites, as well as additional metabolites contributing to oxidative DNA damage, such as PAH quinones. However, both parental PAHs and their metabolites, including PAH quinones or hydroxylated PAHs, have been shown to produce various types of non-genotoxic effects. These include e.g., activation of the aryl hydrocarbon receptor and/or additional nuclear receptors, activation of membrane receptors, including tyrosine kinases and G-protein coupled receptors, or activation of intracellular signaling pathways, such as mitogen-activated protein kinases, Akt kinase and Ca(2+)-dependent signaling. These pathways may, together with the cellular DNA damage responses, modulate cell proliferation, cell survival or cell-to-cell communication, thus contributing to the known carcinogenic effects of PAHs. In the present review, we summarize some of the known non-genotoxic effects of PAHs, focusing primarily on those that have also been shown to be modulated by PAH metabolites. Despite the limitations of the available data, it seems evident that more attention should be paid to the discrimination between the potential non-genotoxic effects of parental PAHs and those of their metabolites. This may provide further insight into the mechanisms of toxicity of this large and diverse group of environmental pollutants.
2017
Zapletal, Ondřej; Tylichová, Zuzana; Neča, Jiří; Kohoutek, Jiří; Machala, Miroslav; Milcová, Alena; Pokorná, Michaela; Topinka, Jan; Moyer, Mary Pat; Hofmanová, Jiřina; Kozubík, Alois; Vondráček, Jan
In: Archives of toxicology, vol. 91, no. 5, pp. 2135–2150, 2017, ISSN: 1432-0738 0340-5761, (Place: Germany).
Abstract | Links | BibTeX | Tags: Benzo(a)pyrene/metabolism/*pharmacokinetics, beta Catenin/metabolism, Butyrate, Butyric Acid/*pharmacology, Colon epithelial cells, Colon/*drug effects/metabolism, CYP1A1, Cytochrome P-450 CYP1A1/genetics/*metabolism, DNA adducts, DNA Adducts/drug effects/metabolism, Enhancer Elements, Genetic/drug effects, HCT116 Cells, Histone Deacetylase 1/antagonists & inhibitors/metabolism, Histone Deacetylase Inhibitors/pharmacology, Histone deacetylases, Histones/metabolism, HT29 Cells, Humans, Inactivation, Metabolic, Polycyclic aromatic hydrocarbons
@article{zapletal_butyrate_2017,
title = {Butyrate alters expression of cytochrome P450 1A1 and metabolism of benzo[a]pyrene via its histone deacetylase activity in colon epithelial cell models.},
author = {Ondřej Zapletal and Zuzana Tylichová and Jiří Neča and Jiří Kohoutek and Miroslav Machala and Alena Milcová and Michaela Pokorná and Jan Topinka and Mary Pat Moyer and Jiřina Hofmanová and Alois Kozubík and Jan Vondráček},
doi = {10.1007/s00204-016-1887-4},
issn = {1432-0738 0340-5761},
year = {2017},
date = {2017-05-01},
journal = {Archives of toxicology},
volume = {91},
number = {5},
pages = {2135–2150},
abstract = {Butyrate, a short-chain fatty acid produced by fermentation of dietary fiber, is an important regulator of colonic epithelium homeostasis. In this study, we investigated the impact of this histone deacetylase (HDAC) inhibitor on expression/activity of cytochrome P450 family 1 (CYP1) and on metabolism of carcinogenic polycyclic aromatic hydrocarbon, benzo[a]pyrene (BaP), in colon epithelial cells. Sodium butyrate (NaBt) strongly potentiated the BaP-induced expression of CYP1A1 in human colon carcinoma HCT116 cells. It also co-stimulated the 7-ethoxyresorufin-O-deethylase (EROD) activity induced by the 2,3,7,8-tetrachlorodibenzo-p-dioxin, a prototypical ligand of the aryl hydrocarbon receptor. Up-regulation of CYP1A1 expression/activity corresponded with an enhanced metabolism of BaP and formation of covalent DNA adducts. NaBt significantly potentiated CYP1A1 induction and/or metabolic activation of BaP also in other human colon cell models, colon adenoma AA/C1 cells, colon carcinoma HT-29 cells, or in NCM460D cell line derived from normal colon mucosa. Our results suggest that the effects of NaBt were due to its impact on histone acetylation, because additional HDAC inhibitors (trichostatin A and suberanilohydroxamic acid) likewise increased both the induction of EROD activity and formation of covalent DNA adducts. NaBt-induced acetylation of histone H3 (at Lys14) and histone H4 (at Lys16), two histone modifications modulated during activation of CYP1A1 transcription, and it reduced binding of HDAC1 to the enhancer region of CYP1A1 gene. This in vitro study suggests that butyrate, through modulation of histone acetylation, may potentiate induction of CYP1A1 expression, which might in turn alter the metabolism of BaP within colon epithelial cells.},
note = {Place: Germany},
keywords = {Benzo(a)pyrene/metabolism/*pharmacokinetics, beta Catenin/metabolism, Butyrate, Butyric Acid/*pharmacology, Colon epithelial cells, Colon/*drug effects/metabolism, CYP1A1, Cytochrome P-450 CYP1A1/genetics/*metabolism, DNA adducts, DNA Adducts/drug effects/metabolism, Enhancer Elements, Genetic/drug effects, HCT116 Cells, Histone Deacetylase 1/antagonists & inhibitors/metabolism, Histone Deacetylase Inhibitors/pharmacology, Histone deacetylases, Histones/metabolism, HT29 Cells, Humans, Inactivation, Metabolic, Polycyclic aromatic hydrocarbons},
pubstate = {published},
tppubtype = {article}
}
Butyrate, a short-chain fatty acid produced by fermentation of dietary fiber, is an important regulator of colonic epithelium homeostasis. In this study, we investigated the impact of this histone deacetylase (HDAC) inhibitor on expression/activity of cytochrome P450 family 1 (CYP1) and on metabolism of carcinogenic polycyclic aromatic hydrocarbon, benzo[a]pyrene (BaP), in colon epithelial cells. Sodium butyrate (NaBt) strongly potentiated the BaP-induced expression of CYP1A1 in human colon carcinoma HCT116 cells. It also co-stimulated the 7-ethoxyresorufin-O-deethylase (EROD) activity induced by the 2,3,7,8-tetrachlorodibenzo-p-dioxin, a prototypical ligand of the aryl hydrocarbon receptor. Up-regulation of CYP1A1 expression/activity corresponded with an enhanced metabolism of BaP and formation of covalent DNA adducts. NaBt significantly potentiated CYP1A1 induction and/or metabolic activation of BaP also in other human colon cell models, colon adenoma AA/C1 cells, colon carcinoma HT-29 cells, or in NCM460D cell line derived from normal colon mucosa. Our results suggest that the effects of NaBt were due to its impact on histone acetylation, because additional HDAC inhibitors (trichostatin A and suberanilohydroxamic acid) likewise increased both the induction of EROD activity and formation of covalent DNA adducts. NaBt-induced acetylation of histone H3 (at Lys14) and histone H4 (at Lys16), two histone modifications modulated during activation of CYP1A1 transcription, and it reduced binding of HDAC1 to the enhancer region of CYP1A1 gene. This in vitro study suggests that butyrate, through modulation of histone acetylation, may potentiate induction of CYP1A1 expression, which might in turn alter the metabolism of BaP within colon epithelial cells.